Industry Insights
Stay informed to stay ahead of your competition with the latest industry trends and insights.
8 feeds
304 followers
43 artículos/semana
Navigating the Impact of the Inflation Reduction Act: Assessing Current Realities and Future Trajectory
AbbVie's Skyrizi proves a worthy Humira successor with nearly matching sales ahead of potential UC nod
Gilead writes $2.4B off Trodelvy as CEO underscores ‘time of focused execution’
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
327 followers
41 artículos/semana
Biotech, Pharmaceutical and Clinical Research News | BioSpace
SeguirRSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by Feedity)
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by Feedity)
358 followers
47 artículos/semana
AbbVie Raises 2024 Profit Outlook, Reports Strong Q1 Sales for Skyrizi and Rinvoq
Pfizer Secures FDA Approval for Hemophilia B Gene Therapy, Launches Warranty
Gilead Touts 5% Revenue Jump, Positions for 2024 Growth and Culls Pipeline
Tessera Cuts Dozens of Jobs Following Positive Preclinical Results
Reporting from the frontiers of health and medicine
634 followers
73 artículos/semana
Opinion: STAT readers respond to First Opinion essays on site-neutral payments, free medical school tuition, and more
Cattle testing for H5N1 bird flu will be more limited than USDA initially announced
Biden administration punts menthol cigarette rule indefinitely
STAT+: Momentum builds for House bill cracking down on Chinese biotechs
Contains all the PharmaTimes latest World News.
289 followers
10 artículos/semana
Scientists reveal new method that could reduce waste from drug manufacturing
Two RNA-binding proteins could contribute to cancer therapy development
CMT Research Foundation funds study investigating treatment for CMT1X disease
MPE launches English Myeloma and AL Amyloidosis European Clinical Trial Navigator
Pharmaceuticals news and pharmaceutical industry analysis - FT.com
SeguirThe latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
The latest drugs, health care and pharmaceutical news from the Financial Times, with expert company and industry analysis on FT.com
408 followers
16 artículos/semana
Science is closing in on the frailties of old age
Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
Bristol Myers Squibb drafts contingency plans for US restrictions on Chinese pharma
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
BioPharma
239 followers
23 artículos/semana
353 followers
3 artículos/semana
Crea tu propio feed de noticias
¿Listo para probarlo?
Comienza una prueba de 14 días, no es necesaria tarjeta de crédito.